Business Description
Shanxi Dayu Biological Functions Co Ltd
ISIN : CNE100005FF2
Total Employee Number:
320Compare
Compare
Traded in other countries / regions
920970.China IPO Date
2022-05-18Description
Shanxi Dayu Biological Functions Co Ltd engages in the research and development of bioengineering technology and product application. Its main products are probiotics, enzyme preparations, fermented traditional Chinese medicine, biological preparations, and veterinary preparations.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.51 | |||||
Debt-to-Equity | 0.61 | |||||
Debt-to-EBITDA | -3.39 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.01 | |||||
Beneish M-Score | -1.43 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -22.1 | |||||
3-Year EBITDA Growth Rate | -67.5 | |||||
3-Year FCF Growth Rate | 49.8 | |||||
3-Year Book Growth Rate | -9.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.19 | |||||
9-Day RSI | 49.74 | |||||
14-Day RSI | 52 | |||||
3-1 Month Momentum % | 4.59 | |||||
6-1 Month Momentum % | -19.71 | |||||
12-1 Month Momentum % | -43.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.65 | |||||
Quick Ratio | 0.25 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 103.84 | |||||
Days Sales Outstanding | 40.11 | |||||
Days Payable | 34.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | -7.2 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 6 | |||||
Operating Margin % | -13.5 | |||||
Net Margin % | -26.74 | |||||
EBITDA Margin % | -24.16 | |||||
FCF Margin % | -44.29 | |||||
OCF Margin % | -9.18 | |||||
ROE % | -18.03 | |||||
ROA % | -10.59 | |||||
ROIC % | -5.38 | |||||
3-Year ROIIC % | -51.25 | |||||
ROC (Joel Greenblatt) % | -12.5 | |||||
ROCE % | -13.28 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 36.42 | |||||
PS Ratio | 4.29 | |||||
PB Ratio | 3.19 | |||||
Price-to-Tangible-Book | 3.55 | |||||
EV-to-EBIT | -20.47 | |||||
EV-to-EBITDA | -20.47 | |||||
EV-to-Revenue | 4.94 | |||||
EV-to-FCF | -11.16 | |||||
Price-to-GF-Value | 0.94 | |||||
Earnings Yield (Greenblatt) % | -4.89 | |||||
FCF Yield % | -10.41 |
Shanxi Dayu Biological Functions Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanxi Dayu Biological Functions Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| 2:1 Stock Split | 2023-06-14 | 4.09 (+0.99%) |
Show
Entries
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||